BLSH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Bullish (BLSH) is not a good buy right now for a beginner investor with a long-term strategy. The company's financial performance is weak, with significant declines in revenue, net income, and EPS. Additionally, the stock has shown a sharp recent decline in price, and there are no strong technical or proprietary trading signals to suggest a reversal. While analysts maintain some positive sentiment with Buy ratings, the reduced price targets and lack of significant positive catalysts make this stock less attractive at the moment.
The MACD is positive but contracting, RSI is neutral at 60.692, and moving averages are converging, indicating no clear trend. The stock is trading near its pivot level of 33.378, with resistance at 36.363 and support at 30.392. Recent price action shows a sharp decline of -4.99% in the regular market and -1.71% in pre-market, suggesting bearish momentum.
Kraken's Federal Reserve master account approval and potential IPO could indirectly benefit the cryptocurrency sector, which BLSH is associated with. Analysts maintain some Buy ratings despite reduced price targets.
Weak financial performance in Q4 2025, including a 445.95% drop in net income and a 441.51% drop in EPS. The stock has shown significant recent price declines, and the options market sentiment is bearish. Analysts have lowered price targets due to a 'risk-off' environment and weak investor sentiment.
In Q4 2025, revenue dropped by -2.55% YoY to $64.35 billion. Net income plummeted by -445.95% YoY to -$546.6 million, and EPS dropped by -441.51% YoY to -3.62. Gross margin also declined by -25.00% YoY to 0.03.
Analysts have mixed views. Clear Street and Citi maintain Buy ratings but have lowered price targets to $42 and $67, respectively. JPMorgan maintains a Neutral rating and has reduced its price target to $41. Analysts cite weak investor sentiment, a risk-off environment, and legislative uncertainty as reasons for the target cuts.
